Phase 3 Readout~month

Phase 3 Topline: A Phase 2/3 Efficacy and Safety Study of KPL-387 Treatment in Participants With Recurrent Pericardit

Indication
Recurrent Pericarditis; Pericarditis; Pericarditis Acute

Other upcoming events for KNSA

Phase 2 ReadoutPhase 2 Readout: kpl-387

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 2/3 Efficacy and Safety Study of KPL-387 Treatment in Participants With Recurrent Pericardit — KNSA Phase 3 Readout | BioSniper